Register for day one
9:00 Registration and networking
10:00 Welcome and conference introduction
David Ramsden, Chief Executive, Cystic Fibrosis Trust
10:05 Setting the scene for day one
Dr Janet Allen, Director of Strategic Innovation, Cystic Fibrosis Trust
10:10 Session one: Development of new therapies for cystic fibrosis
New therapies for cystic fibrosis are under development, and some of these therapies may improve the way existing precision medicines work or cause them to work in a novel and different way. In this session we'll hear from two companies with different approaches, including therapies that may work for anyone irrespective of their genotype.
10:15 The next generation of precision medicines
Proteostasis
10:45 Replace instead of repair – novel therapeutics for all CF patients
Professor Martin Gosling PhD, Chief Scientific Officer, Enterprise Therapeutics
11:10 Coffee and networking (Exhibition area)
11:30 - Session two: Innovative ways to reduce burden of care
Digital health technology has the potential to improve the length and quality of life for people with cystic fibrosis. Our speakers will provide updates on research funded and supported by the Trust, including the feasibility of home monitoring in children, to applying new knowledge gained from analyzing the data generated from home monitoring.
There will be presentations from Professor Andres Floto on SmartCare CF, Professor Jane Davies on CLIMB-CF, Professor John Winn on predicting pulmonary exacerbations, and Professor Kirsty Hill on Project Breathe, followed by a panel discussion.
12:20 Conference lunch
Meet the sponsors’, networking & poster viewing (Exhibition Area)
14:15 Session three: A showcase of Cystic Fibrosis Trust-funded research
Discover which problems Trust-funded researchers are addressing, how they’re doing it and how the answers they discover could make a difference to people living with cystic fibrosis in the future. This will be a whistle-stop tour of some of our world-leading research projects.
15:00 Session four: Regenerative medicine
- Dr Lisa Strug, Sick Kids, Toronto
- Professor Andres Floto, UK CF Innovation Hub based at the University of Cambridge
Hear how advances in our understanding of CF will allow us to tailor care and treatments to each person. We know that CF varies in how it appears in different individuals and in how responses to treatments can vary. Some of these differences are down to variations in our genetic make-up. In this session we’ll hear how genetic and machine learning research can help us understand more and how the CF community can help.
16:00 Coffee & networking
16:30 CF's Got Talent!
Chaired by Cystic Fibrosis Trust supporter, Roger Black MBE, this unique event is an opportunity for our early-career researchers to present their work in a jargon-free way to people with CF and their families.
18:00 Networking drinks reception
19:00 Close